The policy analysis and guidance you need by the experts you trust, daily.
- After Hours
- Agent Oversight
- Brain Food
- Health Insurance Exchanges
- Part D
- Performance Optimization
- Policy & Health Reform
- Prospective Evaluations
- Provider Relations
- Risk Adjustment
- Sales & Marketing
- Star Ratings
- Alan Mittermaier on MA and Part D Proposed Rule Increases Plan Flexibility, Reduces Regulatory Burden
- Sharon Willliams on A New Source of Capital for Star Ratings and Clinical Innovations
- William on Will Trump and Price Pull Out the Scalpels for Star Ratings?
- Bobby on January Release of the Draft MMG – Perfect Timing
- Pam Lassila on Best Practices and Common Conditions of Audit Preparation
Topic: Health Insurance Exchanges
The annual Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameter (NBPP) for 2019 proposed rule was released on October 27, 2017. It contains some eye-opening details about the future path of the Affordable Care Act (ACA). There have been many attempts this year to dismantle and drastically alter the course the ACA set out to achieve. The 2019 NBPP proposed regulations display the same message that has been heard all year – to make many changes to the foundational structure and administration process of the ACA.
With two months of Affordable Care Act (ACA) stabilization bill efforts under the belt, it is becoming questionable whether Congress will be able to pass, or even bring to the floor, a bill President Trump will support and sign. We saw some developments this week that may shape the future of cost sharing subsidy payments as well as any other ACA fixes in the months to come.
Many thought, with the failure of the U.S. Congress to repeal the Affordable Care Act (ACA) at the end of the 2017 fiscal year, the act was safe from another repeal effort under this Congress. While the names in the Senate may remain the same, the effective plan may have now changed. Former Centers for Medicare & Medicaid Services (CMS) Administrator Andy Slavitt has described this as “synthetic repeal.”
Supporters of the Affordable Care Act (ACA) won another huge battle against TrumpCare this week, but the war rages on. The threat will continue to loom until Trump is removed from office, Democrats retake the House or Senate, or the Senate provides him a win with a bipartisan market stabilization bill in the wake of the stinging defeat of Graham-Cassidy, his third failure to repeal the ACA.
On Wednesday, September 6, the Senate HELP Committee kicked off a series of hearings on a possible bipartisan bill to address pressing issues with the individual market under the Affordable Care Act (ACA). The first hearing, the senators heard from five state insurance commissioners from both parties. Notably, the hearing largely avoided partisan rhetoric on the ACA and focused on how substantive short-term solutions should be implemented. Senator Alexander expressed his wish for draft legislation to be introduced next week. More importantly, further insight into what senators may agree on was provided in the first hearing.
Next week’s return of Congress marks the start of a jam-packed agenda for Congress. Not only must Congress fund the government, tackle the increase of the debt ceiling, and reauthorize Federal Aviation, Flood Insurance, and the Children’s Health Insurance Program (CHIP) funding by September 30, lawmakers will also need to tackle a host of other proposals up for consideration. Below are some agenda items that will affect government healthcare programs:
With the failed Affordable Care Act (ACA) repeal effort, senators packed their bags and headed off for August recess. Their return will be met with a significantly packed healthcare agenda: Children’s Health Insurance Program (CHIP) Reauthorization, ACA Stabilization Bill, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act, as well as last ditch efforts to repeal the ACA through bills that have yet to be voted on such as Graham-Cassidy.